Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Rotigotine (Primary)
- Indications Anxiety; Parkinson's disease
- Focus Therapeutic Use
- Acronyms ANXPD
- 29 Aug 2016 Planned End Date changed from 1 Mar 2019 to 1 Jan 2019.
- 29 Aug 2016 Planned primary completion date changed from 1 May 2018 to 1 Dec 2018.
- 29 Aug 2016 Status changed from not yet recruiting to recruiting.